Skip to main content

Test Price

2,800 AED

✅ Home Collection Available

PINK1 Gene (PARK6) Parkinson Genetic Test in UAE | 2,800 AED | DNA Labs UAE

تحليل جين PINK1 (بارك6) لمرض باركنسون في الإمارات | 2800 درهم | مختبرات دي إن إيه

Executive Summary & Core Metrics

  • Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS Processing (Cert: INT/EGQ/2509DA/3139).
  • Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
  • Clinical Guidance: Telephonic Post-Test Clinical Guidance by a DHA-licensed Consultant Medical Geneticist.
  • Insurance: Direct Billing Verification via WhatsApp: +971 54 548 8731.

ملخص تنفيذي: يقدم هذا الفحص الجيني المتطور تسلسلاً كاملاً لجين PINK1 المرتبط بالباركنسون المبكر، بدقة تشخيصية تصل إلى 99.9%، مع خدمة سحب منزلي طبقاً للمواصفات الدولية والامتثال الكامل لقوانين حماية البيانات في الدولة.

Test Overview & Methodology

This test utilizes Next-Generation Sequencing (NGS) to analyze the entire coding region of the PINK1 gene, corresponding to the PARK6 locus linked to autosomal recessive early‑onset Parkinson’s disease. It detects single nucleotide variants, insertions/deletions, and copy number changes with high precision, enabling a definitive molecular diagnosis for targeted management.

Feature Our PINK1 NGS Test Alternative (Targeted Panel)
Methodology Full‑gene NGS with CNV analysis Limited mutation hotspot detection
Coverage All exons & splice sites ±20 bp Selected common pathogenic variants only
Turnaround Time 3–4 Weeks 4–6 Weeks
Diagnostic Yield Up to 10% in recessive families 2–4%
Price (AED) 2,800 2,400

Physician Insight & Safety Protocols

“As a Consultant in Medical Genetics at DNA Labs UAE, I confirm that comprehensive PINK1 gene sequencing is essential for diagnosing autosomal recessive early-onset Parkinson's disease. This test provides a definitive molecular answer that can guide prognosis and family planning. It is crucial to integrate this result with a thorough clinical evaluation and neurological examination.” – Lina Osama Zaki Quteineh, DHA Registration ID: 9294403

Advisory: Medication & Clinical Safety

Do not discontinue prescribed medication (e.g., levodopa, dopamine agonists) without consulting your doctor. Abrupt withdrawal may cause neuroleptic malignant‑like syndrome or severe parkinsonism crisis. Always consult your treating physician before making any changes to your medication regimen.

Exclusion Criteria & Red Flags

Exclusion Criteria: Individuals under 18 years without court‑appointed guardian consent; patients with uncontrolled coagulopathy or acute febrile illness at the time of draw.
Emergency Red Flags: If you experience sudden worsening of tremor, unexplained falls, hallucinations, or severe dyskinesia, stop the home collection request and proceed to the nearest emergency room immediately.

Patient FAQ & Clinical Guidance

1. What exactly does the PINK1 gene test detect?

This NGS assay identifies pathogenic variants in the PINK1 gene that cause early‑onset Parkinson’s disease, including missense, nonsense, and copy number changes. This enables a definitive molecular diagnosis and informs carrier screening for family members.

يكشف هذا الاختبار عن الطفرات المسببة للمرض في جين PINK1 المرتبط بباركنسون المبكر، مما يوفر تشخيصاً جزيئياً دقيقاً ويساعد في فحص أفراد العائلة.

2. Who should consider this test?

Individuals with onset of parkinsonian symptoms before age 40, especially when there is a family history of the disease or consanguinity, benefit most from this test because PINK1 mutations are a major contributor to autosomal recessive juvenile Parkinson’s.

يستفيد من هذا التحليل الأشخاص الذين ظهرت عليهم أعراض باركنسون قبل سن الأربعين، خصوصاً مع وجود تاريخ عائلي أو زواج الأقارب.

3. How is the sample collected and is it painful?

A standard peripheral whole blood sample is collected by a certified phlebotomist during a 15‑minute home visit via our VIP Mobile Phlebotomy service. The procedure feels like a routine blood draw with minimal discomfort and zero downtime.

يتم سحب عينة دم وريدي بسيطة بواسطة فني سحب معتمد خلال زيارة منزلية تستغرق 15 دقيقة، وهي تشبه تحليل الدم العادي ولا تسبب ألماً يُذكر.

UAE Regulatory & Data Privacy Adherence

Fully aligned with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. All genetic data is encrypted, stored within UAE sovereign clouds, and never shared without explicit consent.

Clinical & Logistical Metadata

Test Name PINK1 Gene (PARK6) Sequencing
Price (AED) 2,800
Turnaround Time 3–4 Weeks
Sample Type / Matrix Peripheral Whole Blood
Methodology Used Next-Generation Sequencing (NGS) with CNV Analysis
ICD-10-CM Code G20 (Parkinson's Disease)
LOINC Code 82321-0 (PINK1 gene mutation analysis)
DHA Facility License Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | License No: 1143

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians